Selection and Progress of drugs for treating Dementia

Author:

Al-Hussaniy Hany Akeel1,Al-Samydai Ali2,Abu Hajleh Maha N.3,Mayyas Amal4,I. Oraibi Amjad5

Affiliation:

1. Dr Hany Akeel Institute, Iraqi Medical Research Center, Baghdad, Iraq.

2. Pharmacological and Diagnostic Research Centre, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan.

3. Department of Cosmetic Science, Pharmacological and Diagnostic Research Centre, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, 19328 Amman, Jordan.

4. Department of Pharmacy, Faculty of Health Sciences, American University of Madaba, Madaba 11821, Jordan.

5. Department of Pharmacy, Al-Manara College for Medical Sciences, Amarah, Iraq.

Abstract

Dementia is a major health problem among the elderly around the world; the number of dementia patients, as well as antidementia drugs, has been increasing in recent years. In this paper, we searched the dementia treatment guidelines, domestic and foreign literature reports in the past five years, summarized the classification of dementia, the selection of current pharmacotherapies in dementia, evidence-based evaluation of guidelines and some drugs with clinical treatment prospects to provide a reference for the decision-making of dementia drug therapy.

Publisher

A and V Publications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3